health Buzz

RESEARCH TRIANGLE PARK, Noord-Carolina--(BUSINESS WIRE)--Quintiles, leverancier van biofarmaceutische diensten, heeft het New Health Report 2012 uitgegeven waarin staat dat de kern van een effectiever gezondheidssysteem ligt in een betere risico/waarde beslissing. - er is geen consensus in de biofarmaceutische industrie of bedrijven meer risico moeten accepteren. - betere meetmanieren zijn nodig om het risico en de voordelen voor belanghebbenden nauwkeurig te bepalen. - veel patiënten met chroni - BusinessWire - 0 Reads

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $600 million aggregate principal amount of 1.350% senior notes due 2015 and $650 million aggregate principal amount of 3.200% senior notes due 2022. The offering is expected to close on May 30, 2012. The notes will be CIFSA’s senior unsecured obligations and will rank equally in right of payment with all of its existin - BusinessWire - 0 Reads

HEMET, Calif.--(BUSINESS WIRE)--The KPC Group Completes the Acquisition of Ramona VNA & Hospice and Announces Name Change to Inland Empire Home Health & Hospice - BusinessWire - 0 Reads

COPENHAGEN (Reuters) - Danish biopharma firm Bavarian Nordic said on Tuesday that the U.S. Department of Health and Human Services has supported the initiation of an expanded phase 3 study of its smallpox vaccine Imvamune. - Reuters - 0 Reads

WASHINGTON (Reuters) - Drug reviewers recommended on Tuesday rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. - Reuters - 0 Reads

(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate. - Reuters - 0 Reads

(Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical Co, according to data from a pivotal late-stage trial. - Reuters - 0 Reads

NEW YORK (Reuters Health) - For at least some moms-to-be, it's extra body fat -- and not blood sugar levels -- that may be key to their risk of having a big baby, a study published Tuesday suggests. - Reuters - 0 Reads

NEW YORK (Reuters Health) - Results from a large U.S. study suggest women who regularly exercise vigorously, including runners and aerobics buffs, may be less likely to get psoriasis than less-active women. - Reuters - 0 Reads

NEW YORK (Reuters Health) - Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be fortified with the B vitamin folic acid, a new study finds. - Reuters - 0 Reads